Glimepiride and Nearsightedness - a phase IV clinical study of FDA data

Summary:

Nearsightedness is reported as a side effect among people who take Glimepiride (glimepiride), especially for people who are female, 60+ old, also take Metformin, and have Fluid retention.

The phase IV clinical study analyzes which people have Nearsightedness when taking Glimepiride. It is created by eHealthMe based on reports of 45,086 people who have side effects when taking Glimepiride from the FDA, and is updated regularly.

What is Glimepiride?

Glimepiride has active ingredients of glimepiride. It is often used in diabetes. eHealthMe is studying from 45,910 Glimepiride users. Check the latest studies of Glimepiride.

What is Nearsightedness?

Nearsightedness (difficulty in seeing the far objects) is found to be associated with 470 drugs and 679 conditions by eHealthMe. Check the latest studies of Nearsightedness.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

45,086 people reported to have side effects when taking Glimepiride.
Among them, 15 people (0.03%) have Nearsightedness.

Could Glimepiride cause Nearsightedness?

Among these 15 people:

What is the gender of people who have Nearsightedness when taking Glimepiride? *

female: 100 %
male: 0.0 %

What is the age of people who have Nearsightedness when taking Glimepiride? *

What are other drugs people take besides Glimepiride? *

What are other side effects people have besides Nearsightedness? *

Tooth Abscess (pus formation in tooth): 10 people, 66.67%
High Blood Cholesterol: 9 people, 60.00%
Sinusitis (inflammation of sinus): 9 people, 60.00%
Chest Pain: 9 people, 60.00%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 8 people, 53.33%
Itching: 8 people, 53.33%
Intervertebral Disc Protrusion (spinal disc protrusion): 8 people, 53.33%
Hypermetropia (abnormal condition in which vision for distant objects is better than for near objects): 8 people, 53.33%
Hepatomegaly (abnormal enlargement of the liver): 8 people, 53.33%
Hepatic Pain (pain in liver): 8 people, 53.33%

What are the existing conditions these people have? *

Depression: 8 people, 53.33%
Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 8 people, 53.33%
Fluid Retention (an abnormal accumulation of fluid in the blood): 8 people, 53.33%
Memory Loss: 7 people, 46.67%
Kidney Stones: 5 people, 33.33%
Blood Uric Acid Increased: 5 people, 33.33%
High Blood Cholesterol: 4 people, 26.67%
Stress And Anxiety: 2 people, 13.33%
Blood Calcium Decreased: 2 people, 13.33%
Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 2 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Glimepiride and have Nearsightedness?

- Check whether Nearsightedness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Glimepiride:

Glimepiride (45,910 reports)

Nearsightedness treatments and more:

Nearsightedness (3,338 reports)

Browse all side effects of Glimepiride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nearsightedness:

Nearsightedness (470 drugs)

Browse all the conditions that are associated with Nearsightedness:

Nearsightedness (679 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on glimepiride (the active ingredients of Glimepiride) and Glimepiride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.